FundedIQ
Biotechnology

Auxilius Pharma: Funding, Investors & Team (Oct 2026)

Auxilius Pharma is a cutting-edge, specialized pharmaceutical start-up that is committed to improving drugs that are already approved in some markets but not in others for the benefit of patients and to fill significant unmet medical needs in an environment where the cost of healthcare is becoming increasingly important.

www.auxiliuspharma.com LinkedIn Hudson, United States 1-10 employees
Biotechnology Life Science Pharmaceutical
Total raised
$1.0M
Rounds
1
Latest
Seed
Nov 2022

Auxilius Pharma has raised $1.0M across 1 funding round on record, the most recent a Seed of $1.0M announced in Nov 2022.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Auxilius Pharma Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.0M in Nov 2022
Employees
1-10
reported band
Headquarters
Hudson, United States

Latest funding round on record: Nov 2022.

Auxilius Pharma Funding Rounds

Date
Round
Amount
Seed
$1.0M

Auxilius Pharma Founders and Leadership Team

Name
Role
Contact
Jed Litwiniuk
CEO
Locked

Contact details for the Auxilius Pharma team: 1 of 1 has an email address on file.

Start 14-day free trial →

Auxilius Pharma Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

Auxilius Pharma's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Auxilius Pharma in Biotechnology and Hudson

Companies Similar to Auxilius Pharma

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Auxilius Pharma Funding FAQs

What does Auxilius Pharma do?

Auxilius Pharma is a cutting-edge, specialized pharmaceutical start-up that is committed to improving drugs that are already approved in some markets but not in others for the benefit of patients and to fill significant unmet medical needs in an environment where the cost of healthcare is becoming increasingly important.

How much funding has Auxilius Pharma raised?

Auxilius Pharma has raised $1.0M across 1 round on record. The most recent is a Seed of $1.0M announced in Nov 2022.

When did Auxilius Pharma last raise funding?

Auxilius Pharma's most recent funding round on record is a Seed of $1.0M, announced in Nov 2022.

Who is the CEO of Auxilius Pharma?

Jed Litwiniuk is listed as CEO at Auxilius Pharma.

Where is Auxilius Pharma headquartered?

Auxilius Pharma is based in Hudson, Massachusetts, United States.

How many employees does Auxilius Pharma have?

Auxilius Pharma is in the 1-10 employee band.

How does Auxilius Pharma's funding compare to other Biotechnology startups?

Auxilius Pharma's latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Auxilius Pharma Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Auxilius Pharma is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.